Market Cap (In SEK)
312.07 Million
Revenue (In SEK)
270 Thousand
Net Income (In SEK)
-16.48 Million
Avg. Volume
646.95 Thousand
- Currency
- SEK
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.949266-4.62
- PE
- -
- EPS
- -
- Beta Value
- 1.229
- ISIN
- SE0007413455
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Carol Routledge
- Employee Count
- -
- Website
- https://www.alzinova.com
- Ipo Date
- 2015-11-25
- Details
- Alzinova AB (publ), a biopharma company, engages in the development of an active immunotherapy for the treatment of Alzheimer's disease in Sweden. Its lead candidate is ALZ-101, an oligomer-specific vaccine for the treatment of Alzheimer's disease; and ALZ-201, a monoclonal antibody that is used for the treatment of toxic Aß oligomers. The company was founded in 2011 and is based in Mölndal, Sweden.
More Stocks
-
VINCOFEVINTAGE COFFEE AND BEVERAGES L
VINCOFE
-
BKENBakken Energy Corp.
BKEN
-
OTV2
-
ALEXANDERAlexander Stamps and Coin Limited
ALEXANDER
-
AMNP
-
IMPJYWebuild S.p.A.
IMPJY
-
HITTCOHittco Tools Limited
HITTCO
-
CVUEF